1. Home
  2. SNGX vs XELB Comparison

SNGX vs XELB Comparison

Compare SNGX & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$0.36

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

N/A

Current Price

$0.60

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
SNGX
XELB
Founded
1987
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.4M
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
SNGX
XELB
Price
$0.36
$0.60
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
208.9K
★ 855.2K
Earning Date
11-06-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.03
48.37
EPS
★ N/A
N/A
Revenue
★ $119,371.00
N/A
Revenue This Year
N/A
$30.13
Revenue Next Year
N/A
$99.55
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.52
52 Week High
$1.76
$2.47

Technical Indicators

Market Signals
Indicator
SNGX
XELB
Relative Strength Index (RSI) 21.80 30.39
Support Level N/A N/A
Resistance Level $0.82 $1.16
Average True Range (ATR) 0.01 0.09
MACD 0.00 -0.01
Stochastic Oscillator 42.22 17.12

Price Performance

Historical Comparison
SNGX
XELB

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: